Baxter picks up Sanofi’s Seprafilm adhesion barrier for $350M

Dec 2, 2019
Baxter International said Monday it plans to acquire Sanofi’s surgical products unit Seprafilm and related assets for $350 million in cash, confirming October speculation the Deerfield, Illinois-based healthcare products company and French pharma were weighing a deal.

The deal gives Baxter’s surgery division an adhesion barrier product meant to reduce incidence and severity of postoperative scarring in patients undergoing abdominal or pelvic laparotomy procedures.

Baxter said it expects the deal to close no later than the first quarter of 2020 and anticipates the acquired products to generate $100 million in sales in the year following close.

For more details, please go to

Scroll to Top